Keywords: فارماکوژنومیک; Antipsychotic; Drug response; Neuroleptic; Pharmacogenetics; Pharmacogenomics; Schizophrenia; Tolcapone;
مقالات ISI فارماکوژنومیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکوژنومیک; oral anticoagulant; warfarin; vitamin K antagonist; pharmacogenomics; algorithm
Keywords: فارماکوژنومیک; Electronic health records; Computerized physician order entry; Computer-assisted drug therapy; Clinical decision support systems; Physician's practice patterns; Drug safety; Personalized medicine; Pharmacogenomics;
Keywords: فارماکوژنومیک; SLCO1B1; Anti-HMGCR; Statin-related myopathy; Pharmacogenomics;
Keywords: فارماکوژنومیک; Drug allergy; drug hypersensitivity; desensitization; pharmacogenomics; Stevens-Johnson syndrome; toxic epidermal necrolysis; hapten hypothesis; altered peptide repertoire hypothesis; pharmacologic interaction with immune receptor hypothesis; DR; Drug rea
Keywords: فارماکوژنومیک; Neurotoxicity; Taxane; Breast cancer; Pharmacogenomics; Antioxidants; Antidepressants; Anticonvulsants; Vitamins
Keywords: فارماکوژنومیک; Neonatal abstinence syndrome; Opioids; Circumcision; Analgesia; Pharmacogenomics; Single nucleotide polymorphism;
Keywords: فارماکوژنومیک; CSA; cajanin stilbene acid; E2; 17β-estradiol; ERα; estrogen receptor-α; PR; progesterone receptors; EREs; estrogen response elements; MRI; Magnetic resonance imaging; GA; genetic algorithm; ESR1; estrogen receptor alpha gene; Breast cancer; Estrogen r
Keywords: فارماکوژنومیک; Personalized medicine; Genetics; Genomics; Pharmacogenomics; Prostate cancer; Health technology assessment
Keywords: فارماکوژنومیک; Community pharmacy; pharmacogenomics; personalized medicine;
Keywords: فارماکوژنومیک; CAB; Community Advisory Board; CAP; College of American Pathologists; CDS; clinical decision support; CGSL; Clinical Genome Sequencing Laboratory; CLIA; Clinical Laboratory Improvement Amendments; eMERGE; Electronic Medical Record and Genomics; EMR; elect
Keywords: فارماکوژنومیک; Pharmacogenomics; Prostate cancer; Androgen deprivation therapy; Chemotherapy; Steroid;
Keywords: فارماکوژنومیک; Asthma; child; glucocorticoid; pharmacogenomics; polymorphism; ACRN; Asthma Clinical Research Network; CAMP; Childhood Asthma Management Program; CARE; Childhood Asthma Research and Education network; CLIC; Characterizing Response to Leukotriene Receptor
Keywords: فارماکوژنومیک; AUCÏ; Area under the curve within the dosing interval; BS; Bootstrap; CL; Clearance; CLCR; Creatinine clearance; CP; Cerebral palsy; GAGE; Gestational age; GERD; Gastroesophageal reflux disease; IIV; Inter-individual variability; MTT; Mean transit time;
Keywords: فارماکوژنومیک; Biomarker; Dual-composite null hypothesis; Flexible dual-independent null hypothesis; Pharmacogenomics; Rigorous dual-independent null hypothesis;
Keywords: فارماکوژنومیک; Pharmacogenomics; Text mining; Information extraction; Personalized medicine;
Keywords: فارماکوژنومیک; adverse drug reactions; genome wide association studies; personalized medicine; pharmacogenomics
Keywords: فارماکوژنومیک; Anticoagulants; Congestive heart failure; Pharmacogenomics; Warfarin
Keywords: فارماکوژنومیک; Pharmacogenomics; Genomics; Needs assessment; Information needs; Qualitative inquiry; Pharmacists
Keywords: فارماکوژنومیک; Genomic medicine; Pharmacogenomics; Electronic medical records; Clinical decision support; Clinical informatics
Keywords: فارماکوژنومیک; Pharmacogenomics; Patient education; Warfarin; Individualized medicine
Pharmacogenomics
Keywords: فارماکوژنومیک; Bladder cancer; Pharmacogenomics; Personalized medicine; Immunotherapy; Clinical trials; Molecular subtype; Predictive biomarker; Precision medicine;
Pharmacogenomic Testing to Select Antiplatelet Therapyâ
Keywords: فارماکوژنومیک; acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor;
Pharmacogenetic Labeling of FDA-Approved Drugs
Keywords: فارماکوژنومیک; drug labeling; pharmacogenomics; precision medicine; regulatory perspective; warfarin;
Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients
Keywords: فارماکوژنومیک; Liver transplantation; Tacrolimus; P450; SNP; Pharmacogenomics;
The first free Africans in America: HLA study in San Basilio de Palenque (Colombia)
Keywords: فارماکوژنومیک; HLA; Pharmacogenomics; Transplantation; Disease; Colombia; Afroamericans; First free Afro-Americans; Bantu-Spanish Creole; Haiti; Cartagena; Africans;
Pharmacogenomics in epilepsy
Keywords: فارماکوژنومیک; Pharmacokinetics; Pharmacodynamics; Precision medicine; Epilepsy; Drug resistance; Drug response; Adverse drug reactions; Pharmacogenomics;
The HLA-B*15:02 polymorphism and Tegretol®-induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis
Keywords: فارماکوژنومیک; ADRs; adverse drug reactions; cADRs; cutaneous adverse drug reactions; CBZ; carbamazepine; CI; confidence interval; DNA; deoxyribonucleic acid; DRESS; drug reaction with eosinophilia and systemic symptoms; GABRA1; gamma-aminobutyric acid type A receptor a
Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease
Keywords: فارماکوژنومیک; Biomarker; Parkinson Disease; Precision medicine; Pharmacogenomics;
Pharmacogenomics signature: A novel strategy on the individual differences in drug response
Keywords: فارماکوژنومیک; Pharmacogenomics; Pharmacogenetics; Pharmacogenomics signature;
Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients
Keywords: فارماکوژنومیک; Hematopoietic cell transplant; Pharmacogenomics; IMPDH; MPA; Precision medicine; Graft-versus-host disease;
CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension
Keywords: فارماکوژنومیک; Bosentan; Pulmonary arterial hypertension; Proteoglycan; DMET; Asian; Drug metabolism enzymes and transporters; Affimetrix; Pharmacogenomics; Pharmacogenetics;
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
Keywords: فارماکوژنومیک; Stevens-Johnson; Toxic epidermal necrolysis; HLA; Networks; Pharmacogenomics; Pharmacovigilance; Electronic health record; T cells; Granulysin; ADR; Adverse drug reaction; AMT; Amniotic membrane transplantation; BSA; Body surface area; CPNDS; Canadian Pha
Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells
Keywords: فارماکوژنومیک; PPRH; Survivin; Apoptosis; Pharmacogenomics; Networking; Toxicity;
BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications
Keywords: فارماکوژنومیک; ABC; ATP-binding cassette; AUC; area under the time-concentration curve; BCRP; breast cancer resistance protein; Cmax; maximum concentration; CYP; cytochrome P450; DOAC; direct oral anti-coagulant; GI; gastrointestinal; MRP1; multidrug resistance protei
ReviewInduced pluripotent stem cell-derived cardiomyocytes: A platform for testing for drug cardiotoxicity
Keywords: فارماکوژنومیک; Cardiotoxicity; Human induced pluripotent stem cells; Cardiomyocyte; Pharmacogenomics; Cell signaling; Chemotherapeutics;
CYP2D6 pharmacogenomics
Keywords: فارماکوژنومیک; cyp2d6; Pharmacogenomics; Genomic drug label; Clinical pharmacogenomics; CYP2D6 substrates; Structure of CYP2D6;
A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy
Keywords: فارماکوژنومیک; Pharmacogenomics; Ayurveda; Epilepsy; Therapeutic drug monitoring; CYP2C9; CYP2C19;
Pharmacogenetics of antidepressant response: A polygenic approach
Keywords: فارماکوژنومیک; Antidepressant; Pharmacogenomics; Polygenic risk scores; Major depressive disorder; Schizophrenia;
Systems pharmacology-based identification of pharmacogenomic determinants of adverse drug reactions using human iPSC-derived cell lines
Keywords: فارماکوژنومیک; Adverse drug reactions; Quantitative systems pharmacology; iPSC-derived cell lines; Machine learnings; Pharmacogenomics;
Facile and phase-defined determination of HLA alleles with morpholino-functionalized nanoparticle probes
Keywords: فارماکوژنومیک; Morpholino-functionalized gold nanoparticles; Colorimetric detection; Pharmacogenomics; HLA alleles; Screening;
Primer design for SNP genotyping based on allele-specific amplification-Application to organ transplantation pharmacogenomics
Keywords: فارماکوژنومیک; Primer design; SNP genotyping; Microarray; Pharmacogenomics; Organ transplantation;
Pharmacogenomics in acute lymphoblastic leukemia
Keywords: فارماکوژنومیک; Pharmacogenomics; Acute; Lymphoblastic; Leukemia; ALL; Response; MRD; Toxicity;
Original ResearchA Bayesian Approach for Population Pharmacokinetic Modeling of Alcohol in Japanese Individuals
Keywords: فارماکوژنومیک; Population pharmacokinetics; pharmacogenomics; aldehyde dehydrogenase 2; MCMC Bayesian estimation; NONMEM;
Genetic Determinants of P2Y12 Inhibitors and Clinical Implications
Keywords: فارماکوژنومیک; Clopidogrel; Prasugrel; Ticagrelor; Genotype; CYP2C19; Pharmacogenomics;
CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids
Keywords: فارماکوژنومیک; Drug-gene interaction; Drug-drug-gene interaction; Pharmacogenomics; Pharmacogenetic testing; Opioid; Pain management; Polypharmacy;
Pharmacogenomics in Pain Management
Keywords: فارماکوژنومیک; Allele; Haplotype; Homozygous; Heterozygous; Genotype; Pharmacogenomics; Polymorphisms; Single-nucleotide polymorphisms (SNP); Pain;
Pharmacogenomics in Anesthesia
Keywords: فارماکوژنومیک; Allele; Homozygous; Heterozygous; Genotype; Phenotype; Pharmacogenomics; Polymorphisms; Single-nucleotide polymorphisms (SNP); Genetics;
A systematic evaluation of microRNAs in regulating human hepatic CYP2E1
Keywords: فارماکوژنومیک; microRNA, hsa-miR-214-3p; CYP2E1; Drug metabolizing enzymes; Pharmacogenomics; Inter-individual variability;
Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems
Keywords: فارماکوژنومیک; Pharmacogenomics; Genetic polymorphism; Genetic markers; Drug development; Drug designing; Drug targets; Bioinformatics; Dosage form evaluation and quality by design;